Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025)
Perspective Therapeutics (CATX) reported Receivables - Other of $10000.0 for Q4 2025, down 97.95% on a YoY basis from $487000.0 in Q4 2024, and down 97.95% sequentially from $487000.0 in Q4 2024.
Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025) Analysis & Trends
Perspective Therapeutics (CATX) has 16 years of Receivables - Other data on file, last reported at $10000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other fell 97.95% year-over-year to $10000.0; the trailing twelve-month figure through Dec 2025 stood at $10000.0 (down 97.95% YoY), and the FY2025 full-year result was $10000.0, down 97.95% from the prior year.
- Receivables - Other fell to $10000.0 in Q4 2025, from $487000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $487000.0 in Q4 2024 to a low of $2000.0 in Q4 2022.
- A 5-year average of $93000.0 and a median of $13500.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other jumped 4770.0% in 2024 and slumped 97.95% in 2025, its largest moves.
- Tracing CATX's Receivables - Other over 5 years: stood at $32000.0 in 2021, then sank by 93.75% to $2000.0 in 2022, then soared by 400.0% to $10000.0 in 2023, then jumped by 4770.0% to $487000.0 in 2024, then tumbled by 97.95% to $10000.0 in 2025.
- Business Quant data shows CATX's Receivables - Other at $10000.0 in Q4 2025, $487000.0 in Q4 2024, and $10000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 487,000.00 |
| Dec 31, 2024 | 487,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Jun 30, 2019 | 86,000.00 |
| Jun 30, 2019 | 86,000.00 |
| Jun 30, 2018 | 41,000.00 |
| Jun 30, 2018 | 41,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Jun 30, 2017 | 67,000.00 |